AMRA Medical

View 1 open job Website LinkedIn Careers Page

Focus: AMRA Medical is a Swedish biotech focused on MRI-based body composition analysis, a specialized diagnostic/research tool rather than traditional drug development. The company operates as a lean, innovation-stage organization in the Linköping medtech ecosystem.

Infectious Diseases

Profile data last refreshed 18h ago · AI intelligence enriched 2w ago

Open Jobs

1-3 this month

Stable — net -3 jobs in 30d

1 added, 4 removed. Backfill posture.

Should You Work at AMRA Medical?

AI assessment

AMRA is a mission-driven early-stage play for specialists seeking differentiated expertise in diagnostic biomarkers; career risk is offset by innovation upside, but financial visibility is poor.

Why Work Here

Unique diagnostic technology platform (MRI body composition) offers differentiated skill-building in imaging biomarkers and sarcopenia endpoints—uncommon expertise in pharma

Data completeness

2/9 — Limited

Company HealthSolid

Pipeline

Early-stage

5 total

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Relevance of Sarcopenia in Advanced Liver Disease

Liver Cirrhosis

N/A

Clinical Trials (1)

NCT05502198Relevance of Sarcopenia in Advanced Liver Disease

N/A

Help build intelligence for AMRA Medical

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Early-stage company (founded 2010, 4 open roles) provides meaningful impact opportunity where individual contributions shape product direction

Positioned in growing area of body composition phenotyping for disease modeling, with 5 active clinical trials suggesting validation pathway

Watch Out For

No disclosed revenue, funding, or employee count raises questions about financial stability and runway—typical risk for pre-revenue biotech
Only 4 active job openings and minimal hiring (2 supply chain, 1 dev, 1 science) suggest very slow growth or resource constraints
Single pipeline program (MAsS for sarcopenia in liver disease) with 'N/A' phase classification indicates uncertainty about development stage and timeline

Generated by Claude from AMRA Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

A Comparative Study of MRI and Ultrasound for Detection of Primary Hepatocellular Carcinoma, Body Co

Liver Cirrhoses

N/A

Clinical Trials (1)

NCT07291141A Comparative Study of MRI and Ultrasound for Detection of Primary Hepatocellular Carcinoma, Body Composition and Risk Factors for Decompensation in Liver Cirrhosis

N/A

Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD)

FSHD

N/A

MASLD in Type 2 Diabetes in Primary Care - a Follow-up Study

MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease

N/A

Clinical Trials (1)

NCT07312136MASLD in Type 2 Diabetes in Primary Care - a Follow-up Study

N/A

MAsS

Sarcopenia in Liver Disease